Live Analyst Rating Changes 23633 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Graham Doyle
UBS

Graham Doyle

Wall Street Analyst
★★★★☆
#519
on 13Foresight · ranked by our own returns
71%
Success Rate
+4.8%
Average Return
24 of 34 calls profitable · -1.4% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 71% of Graham Doyle's ratings turned a profit when each position was held for 1 year — averaging +4.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

36 Buy 36 Hold 18 Sell
Graham's Stock Coverage 23 ratings · 2026-08-12
Company Date Position Consensus Price Target 1-Yr Return vs S&P 500
DE:AFX
Carl Zeiss Meditec
Aug 11, 2026 SELL Sell
+54.0% avg upside
13 analysts
$22.60
27.21% Downside
· ·
GB:CTEC
ConvaTec
Aug 06, 2026 BUY Strong Buy
+26.7% avg upside
18 analysts
$375.00
60.05% Upside
· ·
DE:FME
Fresenius Medical Care AG & Co. KGaA
Aug 04, 2026 SELL Hold
+20.3% avg upside
23 analysts
$37.00
11.41% Downside
-1.4% ·
DE:SHL
Siemens Healthineers AG
Aug 03, 2026 HOLD Buy
+25.1% avg upside
24 analysts
$38.00
4.01% Downside
+0.3% ·
NL:PHIA
Koninklijke Philips N.V.
Aug 03, 2026 HOLD Buy
+29.4% avg upside
21 analysts
$24.00
1.89% Upside
+0.4% ·
GEHC
GE Healthcare Technologies Inc
Jul 31, 2026 HOLD Strong Buy
+13.0% avg upside
22 analysts
$73.00
0.03% Upside
+6.3% ·
CH:MOVE
Medacta Group SA
Jul 21, 2026 HOLD Buy
+1.8% avg upside
5 analysts
$148.00
10.92% Upside
+0.5% ·
DE:FRE
Fresenius SE & Co. KGaA
Jun 03, 2026 BUY Strong Buy
+8.9% avg upside
20 analysts
$54.00
14.58% Upside
+27.3% ·
SE:EKTA.B
Elekta AB
May 21, 2026 SELL Strong Sell
+15.6% avg upside
12 analysts
$39.00
25.70% Downside
+18.8% ·
GB:0QBO
Coloplast A/S
May 21, 2026 BUY Buy
+68.2% avg upside
17 analysts
$530.00
23.88% Upside
· ·
CH:ALC
Alcon
May 21, 2026 BUY Buy
+18.5% avg upside
35 analysts
$86.00
40.94% Upside
+5.9% ·
AMBFF
Ambu
May 21, 2026 BUY Buy
+1.8% avg upside
2 analysts
$14.84
36.70% Upside
+9.6% ·
DE:OBCK
Ottobock SE & Co. KGaA
May 21, 2026 BUY Strong Buy
+43.8% avg upside
4 analysts
$74.00
26.30% Upside
+1.4% ·
CH:STMN
Straumann Holding AG
Apr 30, 2026 HOLD Buy
+21.9% avg upside
15 analysts
$90.00
13.76% Downside
+20.6% ·
WILLF
Demant
Apr 15, 2026 BUY Buy
-5.1% avg upside
19 analysts
$37.11
17.40% Downside
+40.1% ·
CH:SOON
Sonova Holding AG
Mar 24, 2026 HOLD Hold
-6.6% avg upside
18 analysts
$215.00
10.02% Downside
+21.7% ·
GB:SN
Smith & Nephew
Mar 17, 2026 HOLD Buy
+1236.5% avg upside
16 analysts
$1300.00
17.30% Upside
-12.2% ·
GB:0QIU
Novo Nordisk
Jan 25, 2022 SELL Hold
+33.5% avg upside
29 analysts
· ·
CH:NOVN
Novartis AG
Jan 25, 2022 HOLD Buy
-11.3% avg upside
32 analysts
+10.5% ·
GB:AZN
AstraZeneca
May 29, 2020 BUY Strong Buy
+23.4% avg upside
26 analysts
-7.5% ·
GB:GSK
GlaxoSmithKline
May 28, 2020 HOLD Hold
+2.1% avg upside
25 analysts
-19.5% ·
DE:BAYN
Bayer
Jan 22, 2020 BUY Strong Buy
+7.1% avg upside
30 analysts
$90.00
83.94% Upside
-26.1% ·
CH:ROP
Roche Holding AG
Jun 20, 2019 HOLD Buy
-8.6% avg upside
23 analysts
$275.00
25.53% Downside
+27.8% ·
🔒 18 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Graham Doyle — Frequently Asked Questions
How accurate are Graham Doyle's stock ratings?
Based on the calls 13Foresight could measure, about 71% of Graham's ratings were profitable over a one-year hold, with an average return of +4.8% per rating, or -1.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Graham ranked on 13Foresight?
Graham Doyle is currently ranked #519 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Graham cover?
Graham most recently has ratings on DE:AFX, GB:CTEC, DE:FME, DE:SHL, NL:PHIA, GEHC, CH:MOVE, DE:FRE, SE:EKTA.B, GB:0QBO, CH:ALC, AMBFF and 11 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.